Transparency Market Research (TMR) has published a new report
titled, “Gastrointestinal Bleeding Treatment Market - Global Industry Analysis,
Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report,
the global gastrointestinal bleeding treatment
market was
valued at US$ 575.3 Mn in 2017 and is projected to expand at a CAGR of 4.5%
from 2018 to 2026. Rise in prevalence of gastrointestinal bleeding with age,
increase in incidence of re-bleeding cases, and surge in adoption of endoscopic
hemostasis as the primary line of treatment for gastrointestinal bleeding
contribute to the growth of the global market.
Request a PDF
Sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=47580
Adoption of
Endoscopic Hemostasis as Primary Line of Treatment for GI Bleeding to Propel
Segment
The report offers detailed segmentation of the global
gastrointestinal bleeding treatment market. Based on product, the market has
been segmented into endoscopic hemostatic devices, closure devices, and others.
The endoscopic hemostatic devices segment has been categorized into thermal
devices and mechanical devices. The endoscopic hemostatic devices segment
dominated the market in 2017 and the trend is likely to continue during the
forecast period. The segment is expected to grow at a high CAGR from 2018 to
2026. Growth of the segment can be attributed to the usage of endoscopic
hemostasis as the primary line of treatment for gastrointestinal bleeding. Rise
in demand for these devices is owing to their ability to restore hemostasis in
majority of the cases. Moreover, increase in usage of combination therapies
contributes to the growth of the segment.
Enquiry
Before Buying Gastrointestinal Bleeding Treatment Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=47580
Upper GI
Tract Segment to Expand Rapidly
Based on GI tract division, the market has been segregated into
upper GI tract and lower GI tract. The upper GI tract segment dominated the
market in 2017 and is anticipated to continue to dominate the market during the
forecast period. The segment is likely to expand at a high CAGR from 2018 to
2026. Higher rate of hospitalization due to upper GI tract bleeding, higher
prevalence than lower GI tract bleeding, and ease of diagnosis of upper GI
tract bleeding contribute to the growth of the segment. Moreover, incidence of
upper gastrointestinal bleeding rises with age owing to increase in consumption
of non-steroidal anti-inflammatory drugs (NSAIDs) which provoke ulcerogenensis
in elderly patients.
Request For Discount - https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=47580
Hospitals
Segment Held Major Share
In terms of end-user, the global gastrointestinal bleeding
treatment market has been divided into hospitals, clinics, ambulatory surgical
centers, and others. The hospitals segment held prominent share of the market
in 2017. Growth of the segment can be attributed to increase in the rate of
hospitalizations and favorable reimbursement policies in hospitals.
Request For Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=47580
Asia Pacific
Market to be Driven by Rise in Prevalence of Gastrointestinal Bleeding among
Geriatric Population
In terms of revenue, North America dominated the global
gastrointestinal bleeding treatment market in 2017. The market in Asia Pacific
is anticipated to grow at a rapid pace during the forecast period. Growth of
the gastrointestinal bleeding treatment market in the region is attributed to
increase in geriatric population and rise in prevalence of GI bleeding with
age. The primary cause of UGIB in India is oesophagial varices which is
reported in over 60% of the patients. Furthermore, the incidence of UGIB
increases with age owing to rise in consumption of non-steroidal
anti-inflammatory drugs (NSAIDs) which causes ulcerogenensis in elderly
patients. The primary causes of LGIB in India are enteric ulcers, followed by
neoplasm, tubercular ulcers, angiodysplasia, amoebic ulcers, and others.
Buy now
Gastrointestinal Bleeding Treatment Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=47580<ype=S
Product
Launches and Geographic Expansion are Primary Strategies Adopted by Market
Players
The report also provides profiles of leading players operating in
the global gastrointestinal bleeding treatment market. These include Boston
Scientific Corporation, Cook Medical, Olympus Corporation, CONMED Corporation,
Ovesco Endoscopy AG, Erbe Elektromedizin GmbH, US Endoscopy (a subsidiary of
STERIS plc), and US Medical Innovations, LLC. Market players have adopted the
strategy of product launches to enhance their customer base. For instance, in
2018, Cook Medical launched its Hemospray in the U.S., a topical agent for the
treatment of gastrointestinal bleeding. Broad market presence, cross-selling
opportunity, comprehensive product portfolio, and new product launches are the
key strategies adopted by leading players in the market.
More Trending Reports by
Transparency Market Research:
https://www.prnewswire.co.uk/news-releases/growth-in-older-population-drives-demand-opportunities-in-surgical-drainage-devices-market-tmr-879678955.html
https://www.prnewswire.com/news-releases/new-models-in-organoids-market-open-new-vistas-in-stem-cell-research-for-cancer-global-valuation-to-reach-us-12-8-bn-by-2030-tmr-301206242.html
About Us
Transparency Market Research is a global market intelligence
company, providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. Our experienced team
of Analysts, Researchers, and Consultants, use proprietary data sources and
various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team
of research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability, Transparency Market
Research employs rigorous primary and secondary research techniques in
developing distinctive data sets and research material for business reports.
Contact
Transparency
Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/